newsTrial supports use of fluvoxamine in patients with mild COVID-197 October 2020 | By Victoria Rees (European Pharmaceutical Review)A clinical trial has demonstrated that the likelihood of hospitalisation was significantly reduced for patients with mild COVID-19 when given fluvoxamine.